Revolutionizing Healthcare with RWD / RWE to Accelerate Regulatory Decision Making
Real-world data and real-world evidence are poised to keep making strides in 2023. This analysis of clinical evidence studies the usage, potential advantages and risk of a medical product inferred from the real-world data analysis. Real-world evidence (RWE) is accelerating its involvement in the early benefit elucidation of medicinal drugs.
RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions. Since RWE research is still in an evolution process, and few gaps in the area have been explored, more guidance and a consented annotation is obligatory to increase the effectuation of real-world data.
After five successful editions of Real-World Evidence and Life Sciences Analytics Conference in Boston, USA, MarketsandMarkets is proud to announce its upcoming Europe edition of Real-World Evidence and Life Sciences Analytics Conference to be held on October 5th- 6th 2023 in Frankfurt, Germany. The conference will bring the full spectrum of experts, leaders, and stakeholders to share a board prospective on significant points and hold discussions on the best practices with a key takeaway being better decision making.
Regulatory view around data quality & data standards.
Leveraging RWE for improving market access.
The adoption & role of AI & ML in clinical trials.
Real-world evidence & Digital Health - The expanded role of RWE for digital health.
Real-World Data & Advanced Analytics.
RWE to inform decision making process in rare diseases where there is lack of evidence.
Learn about the recent trends and advancements in Real-World Evidence Generation
Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers
From Pharmaceutical and Biopharmaceutical companies
Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-